An approach that’s bold
An approach that’s bold
An approach that’s bold
Driven by hope
Driven by hope
Driven by hope
Dedication that’s real
Dedication that’s real
Dedication that’s real

Innovative therapeutics that target
serious viral diseases

Assembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology to pursue novel antivirals with the potential to change the paradigm for the treatment of serious diseases. Our ambitious and compassionate work has the potential to change lives.

Discover our pipeline
Scientific woman

Our herpesvirus portfolio

programs for high-recurrence genital herpes and transplant-associated herpesviruses are designed to address serious consequences of these infections and provide significant innovation over current standard of care.

Learn more
rotating circle rotating circle

Our chronic hepatitis D and hepatitis B programs

aim to improve outcomes for patients facing the significant burden associated with chronic infection.

Explore programs

Passionate. Purpose driven. Patient focused.

Explore opportunities to join our team. We are collectively inspired by and committed to developing novel antivirals that improve the lives of patients facing serious viral diseases.

Join us!
three scientific people
In the News
June 18, 2024
Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 for the Treatment of Chronic Hepatitis B Virus Infection
June 17, 2024
Assembly Biosciences Announces $12.6 Million in Equity Financings
June 10, 2024
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
    rotating circle rotating circle